JUVE.MIJUVE.MIMIL
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank43
5Y CAGR-3.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
-3.9%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202520.24%+466.1%
2024-5.53%-134.7%
202315.94%+303.3%
2022-7.84%-269.8%
20214.62%-81.3%
202024.72%+3.3%
201923.94%+1.5%
201823.58%-43.4%
201741.67%+40.8%
201629.59%-